1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Acquired Storage Pool Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akkerman, JW; Bruijnzeel, PL; Burgers, JA; Koenderman, L; Schweizer, RC | 1 |
| Candler, RV; Carroll, RC; Jones, JB; Lothrop, CD; Pratt, HL; Urso, IM | 1 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Acquired Storage Pool Disease
| Article | Year |
|---|---|
Human platelets secrete chemotactic activity for eosinophils.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Azepines; Blood Platelets; Calcium; Chemotactic Factors; Chemotaxis, Leukocyte; Cytoplasmic Granules; Cytosol; Eosinophils; Humans; Platelet Activating Factor; Platelet Factor 4; Platelet Storage Pool Deficiency; Prostaglandin Endoperoxides; Thromboxane A2; Triazoles | 1993 |
Characterization of platelet function in cyclic hematopoietic dogs.
Topics: Animals; Blood Proteins; Dog Diseases; Dogs; Female; Hematopoiesis; Heterozygote; Male; Neutropenia; Periodicity; Phosphorylation; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Storage Pool Deficiency; Thrombin; Type C Phospholipases | 1991 |